Jan 13, 2022
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research (Bender and Hellerstein)
Published: Jan 13, 2022
Psychopharmacology
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research (Bender and Hellerstein)
Published: Jan 13, 2022
Psychopharmacology
Updates on the latest peer-reviewed & preprint psychedelic research and clinical trials. Twitter handle @UpdatesPsy or @UpdatesPsy@mastodon.social on Mastodon.